Assessing smoking cessation services and pharmacotherapy in Namibia : findings and implications for future policy initiatives
Hango, Ester and Amakali, Kristofina and Shilunga, Anna and Kibuule, Dan and Godman, Brian and Kalemeera, Francis (2022) Assessing smoking cessation services and pharmacotherapy in Namibia : findings and implications for future policy initiatives. Expert Review of Pharmacoeconomics and Outcomes Research, 22 (4). pp. 699-710. ISSN 1473-7167 (https://doi.org/10.1080/14737167.2022.2000863)
Preview |
Text.
Filename: Hango_etal_ERPOR_2021_Assessing_smoking_cessation_services_and_pharmacotherapy_in_Namibia.pdf
Accepted Author Manuscript Download (1MB)| Preview |
Abstract
Background: Tobacco smoking is a considerable barrier to reducing morbidity and mortality associated with non-communicable diseases (NCDs). However, few studies in sub-Saharan Africa have explored access to smoking cessation programs including smoking cessation pharmacotherapy (SCP). This needs to be addressed given the growing burden of NCDs across sub-Saharan Africa including Namibia. Methods: Multi-facility cross sectional survey among physicians in both public and private sectors in Namibia. Results: Of the 106 physicians recruited, 69% practiced in public health facilities and 92% were non-smokers. 67% offer smoking cessation services, with 64% of these offering SCP. This was mainly nicotine replacement therapy (53%) and bupropion SR (41%). Overall, all physicians had a low knowledge score of SCP (<50%). The mean knowledge score though was 77% lower among physicians in public versus private sectors (OR=0.23, 95%CI: 0.14-0.35, p<0.001). Principal barriers to prescribing SCP were inadequate knowledge and/or lack of smoking cessation guidelines. This is not surprising with SCP medicines not currently listed within the public medicine list in Namibia. Conclusion: Despite good attitudes towards SCP, there are concerns with physicians’ knowledge and practices especially in the public sector. There is an urgent need to address this and integrate services to reduce NCDs in Namibia.
-
-
Item type: Article ID code: 78340 Dates: DateEvent14 June 2022Published8 December 2021Published Online28 October 2021AcceptedSubjects: Medicine > Pharmacy and materia medica Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Pure Administrator Date deposited: 01 Nov 2021 12:34 Last modified: 16 Nov 2024 01:20 URI: https://strathprints.strath.ac.uk/id/eprint/78340